Abstract
African Americans manifest an inordinately high burden of hypertension, pressure-related target-organ injury (eg, left ventricular hypertrophy, stroke), and sub-optimal hypertension control rates to conventional levels (<140/90 mm Hg). A substantive proportion of the excessive premature mortality in African Americans relative to Whites is pressure-related. Randomized prospective pharmacologic hypertension end-point trials have shown invariable cardiovascular disease (CVD) risk reduction across a broad range of pre-treatment BP levels down to 110/70 mm Hg with the magnitude of CVD risk reduction across the 5 major antihypertensive drug classes being directly linked to degree of blood pressure (BP) lowering. Pooled endpoint data from pharmacologic hypertension trials in African Americans showed that CVD risk reduction was the same with major antihypertensive drug classes when similar levels of BP were achieved. A lower than conventional BP target for African Americans seems justified and prudent because attainment of lower BP should incrementally lower CVD risk in this high-risk population
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Prospective Studies Collaboration. Age-specific relevance of usual pressure to vascular mortality: a meta-analysis of individual data for 1 million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
•• Law MR. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiologic studies. BMJ. 2009;338:1–19. An aggregation of hypertension clinical trial endpoint data that provides relative risk estimates for CHD and stroke across a broad range of pre-treatment BPs.
Flack JM, Gardin JM, Yunis C, Liu K. Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the CARDIA study. Am Heart J. 1999;138(5 Pt 1):856–64.
Hefferman KS, Jae SY, Wilund KR, et al. Racial differences in central blood pressure and vascular function in young men. Am J Physiol Heart Circ Physiol. 2008;295:H2380–7.
Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;xx:xxxx.
Drazner MH, Dries DL, Peshock RM, et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension. 2005;46:124–9.
Dyer AR, Liu K, Walsh M, et al. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens. 1999;13:13–21.
Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. Population in 1988–2006. Diabetes Care. 2010;33:562–8.
Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995;273:1592–7.
Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics– 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–e181.
Flack JM, Neaton JD, Daniels B, Esunge P. Ethnicity and renal disease: lessons from Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis. 1993;21(Suppl):31–40.
Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233–41.
•• Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360:1179–90. An important prospective epidemiologic longitudinal epidemiologic study showing the strikingly higher risk of heart failure in middle-aged African Americans relative to Whites. The study also highlights the importance of blood pressure in causing heart failure.
Zhang X, Saaddine JB, Chou C-F, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649–56.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;12(317):703–13.
• Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6:497–502. A sobering analysis of national probability data showing the thousands of deaths from stroke and CHD that could be prevented by equalizing the SBP in hypertensive African Americans and Whites.
Centers for Disease Control. Compressed mortality file: underlying cause-of-death. National Center for Health Statistics. 2008. Available at: http://wonder.cdc.gov/mortSQL.html.
•• Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks Consensus Statement. Hypertension. 2010;56:780–800. An update of the first ISHIB Consensus Statement (2003) on the treatment of hypertension in Blacks. This Consensus Statement recommended a target BP < 135/85 mm Hg for African Americans without pre-clinical CVD, target-organ injury, or known vascular disease.
Wright Jr JT, Agodoa LY, Appel L, et al. New recommendations for treating hypertension in black patients: evidence and/or consensus? Hypertension. 2010;56:801–3.
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–52.
Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med. 2004;141:614–27.
• Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;302:831–41. This analysis shows the relatively low level of data used to make the majority of Class I recommendations in AHA/ACC clinical guidelines. This precedent is important when considering the strength of the data used to recommend the lower target BP (< 135/85 mm Hg) for African Americans in the ISHIB Consensus Statement.
Weir MR, Bakris GL, Weber MA, et al. Renal outcomes in hypertensive Black patients at high cardiovascular risk. Kidney Int. 2012;81:568–76.
Neaton JD, Grimm Jr RH, Prineas RJ, et al. Treatment of mild hypertension study: final results. JAMA. 1993;270:713–24.
Verdecchia P, Staessen JA, Angeli F, et al. Usual vs tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomized trial. Lancet. 2009;374:525–33.
Lopes AA, Andrade J, Noblat AC, Silveira MA. Reduction in diastolic blood pressure and cardiovascular mortality in nondiabetic hypertensive patients. A reanalysis of the HOT study. Arg Bras Cardiol. 2001;77:132–7.
Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy, and strokes. Kidney Int. 2002;61:1086–97.
Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000;23(Suppl):B54–64.
ACCORD Study Group. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.
Disclosure
Conflicts of interest: J.M. Flack has received grant support from the NIH, Novartis, Medtronic and Daiichi Sankyo. He serves as a consultant to Medtronic, Back Beat Hypertension, NIH and Novartis; T. Okwuosa, R. Krishamoorthi, B. Ference: none; P. Levy has received grant support from The Robert Wood Johnson Foundation Physician Faculty Scholars Program-Grant #64319.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Flack, J.M., Okwuosa, T., Sudhakar, R. et al. Should African Americans Have a Lower Blood Pressure Goal than Other Ethnic Groups to Prevent Organ Damage?. Curr Cardiol Rep 14, 660–666 (2012). https://doi.org/10.1007/s11886-012-0314-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-012-0314-6